• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evommune, Inc. Common Stock (NY:EVMN)

23.67 +0.54 (+2.33%)
Official Closing Price Updated: 7:00 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 275,688
Open 22.31
Bid (Size) 21.20 (100)
Ask (Size) 25.08 (100)
Prev. Close 23.13
Today's Range 22.31 - 24.82
52wk Range 13.88 - 33.20
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Under‑the‑Radar Biotech to Buy for Potential 10X Growth in the Next Decade ↗
March 10, 2026
Evommune has two autoimmune disorder treatments with blockbuster potential. 
Via The Motley Fool
News headline image
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
March 05, 2026
From Evommune, Inc.
Via Business Wire

Performance

YTD
+36.7%
+36.7%
1 Month
-15.1%
-15.1%
3 Month
+37.5%
+37.5%
6 Month
+17.0%
+17.0%
1 Year
+17.0%
+17.0%

More News

Read More
The trading volume of these stocks is deviating from the norm in today's session. ↗
February 13, 2026
Via Chartmill
News headline image
Evommune Announces $125 Million Private Placement
February 12, 2026
From Evommune, Inc.
Via Business Wire
This Biotech Stock Nearly Doubled In Value Today Morning – What’s Driving Investor Optimism? ↗
February 10, 2026
Via Stocktwits
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
February 11, 2026
Via Chartmill
Top stock movements in today's session. ↗
February 10, 2026
Via Chartmill
Here are the top movers in Tuesday's session. ↗
February 10, 2026
Via Chartmill
These stocks are gapping in today's session ↗
February 10, 2026
Via Chartmill
Top movers in Tuesday's pre-market session ↗
February 10, 2026
Via Chartmill
News headline image
Evommune Announces Positive Top-line Data from Phase 2a Proof-of-Concept Trial of EVO301 in Moderate-to-Severe Atopic Dermatitis
February 10, 2026
From Evommune, Inc.
Via Business Wire
News headline image
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 ↗
January 19, 2026
Via MarketBeat
News headline image
Evommune Reports Third Quarter 2025 Financial Results and Provides Business Update
December 11, 2025
From Evommune, Inc.
Via Business Wire

Frequently Asked Questions

Is Evommune, Inc. Common Stock publicly traded?
Yes, Evommune, Inc. Common Stock is publicly traded.
What exchange does Evommune, Inc. Common Stock trade on?
Evommune, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Evommune, Inc. Common Stock?
The ticker symbol for Evommune, Inc. Common Stock is EVMN on the New York Stock Exchange
What is the current price of Evommune, Inc. Common Stock?
The current price of Evommune, Inc. Common Stock is 23.67
When was Evommune, Inc. Common Stock last traded?
The last trade of Evommune, Inc. Common Stock was at 03/26/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap